drugset / Trial / NCT03884530

Ticagrelol Versus Aspirin in Ischemic Stroke

NCT03884530

RandomizedParallel-groupOpen-labelTreatment

Summary

There is a debate whether ticagrelor is superior to aspirin in treating patients with ischemic stroke or not, most of the studies examine the effect of both drugs within 24 hours of acute stroke some find that there is no difference between ticagrelor and aspirin, others find that ticagrelor is superior to aspirin. At this study the investigators aim at evaluating the role of loading ticagrelor received within 9 hours of acute ischemic stroke in improving neurological outcome of stroke. And evaluating the risk of hemorrhagic and non- hemorrhagic complications associated with the use of ticagrelor180 ml oral loading dose within 9 hours acute ischemic stroke

Timeline

Start
2019-05-01
Primary completion
2020-09-30
Completion
2020-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 75 mg Oral
Comparator Ticagrelor Small molecule 90 mg Oral

Indications